CrossrefInfokarte
Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E42
DOI: 10.3816/clm.2009.n.103 ↗Abstract
Kein Abstract verfügbar.
EUVIMED